AGEN.NASDAQAgenus INC

Form 4: Agenus Inc. CEO Garo Armen Receives Stock in Lieu of Cash Salary

Sentiment:

SEC Form 4


Agenus Inc. CEO Garo Armen received 3,530 shares of common stock at $4.62 per share in lieu of cash salary for the pay period ending October 18, 2024, while also reporting other transactions and holdings.

Summary

  • Garo H. Armen, CEO of Agenus Inc., received 3,530 shares of Agenus common stock on October 18, 2024, as payment in lieu of cash salary.
  • The stock was issued at a price of $4.62 per share, which was the closing price of Agenus common stock on that date.
  • These shares were issued under the Amended and Restated Agenus Inc. 2019 Equity Incentive and are fully vested upon issuance.
  • Armen also reported indirect ownership of 31,298 shares held in IRA accounts and 28,950 shares held as trustee and general partner.
  • The reporting person is a director and officer (Chairman and CEO) of Agenus Inc.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock transactions. The CEO taking salary in stock could be seen as a positive sign, but it's not definitively bullish.

Positives

  • The CEO's decision to take salary in stock may signal confidence in the company's future performance.
  • The stock is fully vested upon issuance, aligning the CEO's interests with those of the shareholders.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It reflects a trend of aligning executive compensation with company performance through equity-based awards.

Comparison to Industry Standards

  • Many companies use equity-based compensation to align executive interests with shareholder value.
  • The specific amount and vesting schedule of the stock awards would need to be compared to peer companies to assess if it is in line with industry standards.
  • Companies like Amgen, Gilead, and Regeneron also utilize stock options and restricted stock units as part of their executive compensation packages.

Stakeholder Impact

  • Shareholders may view the CEO accepting stock in lieu of cash as a positive sign of confidence in the company.
  • Employees may see this as a commitment from leadership to the long-term success of the company.

Key Dates

DateDescription
10/18/2024Date of transaction: Garo Armen received stock in lieu of cash salary.
10/18/2024Payroll date for the pay period ending October 18, 2024.
10/21/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.